Dr Reddy’s shares fell after Goldman Sachs and Citigroup turned cautious, citing limited growth visibility, pipeline concerns and valuation risks. Brokerages flagged lower earnings potential amid generics pricing pressure and muted opportunities in semaglutide. Despite earlier optimism, analysts see downside risks persisting in the near term.
ITC shares gain 3% after Q1 results. Here’s why Nomura upgraded the stock to Buy
ITC shares rose 2% after the FMCG major reported June-quarter results, despite a 27% YoY decline in standalone net profit. Revenue grew 28%, while Nomura